Standard BioTools Inc. (NASDAQ:LAB) Q1 2024 Earnings Call Transcript
Operator: Good day and welcome to the Standard BioTools Inc. First Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode.
Standard Biotools Inc. (LAB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Casdin Capital Eli Casdin | 61,907,605 | $167,769,610 | +5059% | 12.47% |
| 2. | Viking Global Andreas Halvorsen | 58,651,170 | $158,944,671 | 0.59% | |
| 3. | Millennium Management Israel Englander | 14,373,199 | $38,951,369 | +873% | 0.01% |
| 4. | ARK Investment Management Catherine D. Wood | 13,042,440 | $35,345,012 | 0.24% | |
| 5. | 23,190,000 | $25,715,391 | -43% | 16.78% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.62 | 1,403 | Large Shareholder, Director | 11,497,928 | 2024-03-05 | Filing | |
| $2.57 | 250,000 | Large Shareholder, Director | 11,496,525 | 2024-03-04 | Filing | |
| $2.29 | 42,492 | Officer | 85,984 | 2023-05-19 | Filing | |
| $2.22 | 43,492 | Officer | 43,492 | 2023-05-18 | Filing | |
| $2.29 | 800,000 | Large Shareholder, Director | 1,200,000 | 2023-05-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.06 | 84,820 | Officer | 145,347 | 2020-11-23 | Filing | |
| $5.40 | 577,197 | Large Shareholder, Other | 6,909,871 | 2019-09-17 | Filing | |
| $5.55 | 10,038 | Large Shareholder, Other | 7,487,068 | 2019-09-11 | Filing | |
| $5.56 | 1,507 | Large Shareholder, Other | 7,497,106 | 2019-09-11 | Filing | |
| $7.01 | 151,011 | Large Shareholder, Other | 8,271,611 | 2019-08-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,042,413 | $15,563,733 | 5.24% | |
| 2. | 4,365,813 | $9,680,298 | 0% | |
| 3. | 4,133,939 | $9,136,005 | 0% | |
| 4. | 3,928,646 | $8,682,308 | 0% | |
| 5. | 3,053,943 | $6,749,214 | 0% |
News See All
Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript
Standard BioTools Inc. beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.13.
Standard BioTools Inc. (NASDAQ:LAB) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Standard BioTools' Third Quarter 2023 Financial Results Conference Call. As a reminder this conference is being recorded.
Standard BioTools Inc. (NASDAQ:LAB) Q2 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Standard BioTools Inc., Second Quarter 2023 Financial Results Conference Call. As a reminder, this conference is being recorded.
Standard BioTools Inc. (NASDAQ:LAB) Q1 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Standard BioTools Incoporated First Quarter 2023 Financial Results Conference Call. As a reminder, this conference is being recorded.
Standard BioTools Inc. (NASDAQ:LAB) Q4 2022 Earnings Call Transcript
Operator: Hello, and welcome to the Standard BioTools Inc. Fourth Quarter and Full Year 2022 Financial Results Conference Call. As a reminder, this conference is being recorded.
5 Best Micro-Cap Stocks to Buy According to Hedge Funds
In this article, we discuss the 5 best micro-cap stocks to buy according to hedge funds.
Billionaire Hedge Funds
